PHARMACIE TRINATIONALE 2 : revenue, balance sheet and financial ratios

PHARMACIE TRINATIONALE 2 is a French company founded 8 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT-LOUIS (68300), this company of category PME shows in 2023 a revenue of 7.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE TRINATIONALE 2 (SIREN 835295130)
Indicator 2024 2023 2022 2021 2020 2019 2018
Revenue N/C 7 184 020 € 7 239 605 € 6 919 695 € 6 619 942 € 6 718 413 € 3 719 394 €
Net income 372 774 € 389 892 € 568 754 € 544 248 € 298 442 € 508 814 € -103 096 €
EBITDA N/C 457 071 € 563 578 € 642 457 € 520 433 € 787 471 € -11 498 €
Net margin N/C 5.4% 7.9% 7.9% 4.5% 7.6% -2.8%

Revenue and income statement

In 2024, PHARMACIE TRINATIONALE 2 generates positive net income of 373 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

372 774 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 402%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 18%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

402.299%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

17.967%

Solvency indicators evolution
PHARMACIE TRINATIONALE 2

Sector positioning

Debt ratio
402.3 2024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average +8 pts over 3 years

In 2024, the debt ratio of PHARMACIE TRINATIONALE 2 (402.30) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
17.97% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch -11 pts over 3 years

In 2024, the financial autonomy of PHARMACIE TRINATIONALE 2 (18.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
15.67 years 2023
2022
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Watch

In 2023, the repayment capacity of PHARMACIE TRINATIONALE 2 (15.67) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE TRINATIONALE 2

Positioning of PHARMACIE TRINATIONALE 2 in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE TRINATIONALE 2 is estimated at 5 204 200 € (range 3 624 123€ - 7 785 781€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
3624k€ 5204k€ 7785k€
5 204 200 € Range: 3 624 123€ - 7 785 781€
NAF 5 année 2024

Valuation method used

Net Income Multiple
372 774 € × 14.0x = 5 204 201 €
Range: 3 624 123€ - 7 785 782€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE TRINATIONALE 2 with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE TRINATIONALE 2

What is the revenue of PHARMACIE TRINATIONALE 2 ?

The revenue of PHARMACIE TRINATIONALE 2 in 2023 is 7.2 M€.

Is PHARMACIE TRINATIONALE 2 profitable?

Yes, PHARMACIE TRINATIONALE 2 generated a net profit of 373 k€ in 2024.

Where is the headquarters of PHARMACIE TRINATIONALE 2 ?

The headquarters of PHARMACIE TRINATIONALE 2 is located in SAINT-LOUIS (68300), in the department Haut-Rhin.

Where to find the tax return of PHARMACIE TRINATIONALE 2 ?

The tax return of PHARMACIE TRINATIONALE 2 is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE TRINATIONALE 2 operate?

PHARMACIE TRINATIONALE 2 operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.